美股異動 | Meta跌2% 歐盟對其展開反壟斷調查
格隆匯3月12日丨Meta(FB.US)跌2.36%,報190.6美元,總市值5188億美元。消息面上,歐盟英國聯手發起調查,谷歌和Meta涉嫌非法操縱數字廣吿市場。有關調查是針對這兩家科技巨頭在2018年的一項交易,據説該交易在網絡廣吿市場上給予它們優惠待遇,小公司因此受到影響。另外,“META”公司對其仇恨言論政策做出臨時改變,將允許一些國家的社交媒體用户,在其旗下的社交軟件臉書和Instagram上發出“呼籲暴力抵抗俄羅斯人和俄羅斯士兵”,甚至針對俄羅斯總統普京的仇恨言論。據俄新社,俄羅斯總檢察院發佈消息稱,要求法院認定美國“META”公司為極端組織,並禁止其在俄羅斯開展經營活動。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.